Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like Phoenix Molecular Designs Appoints Leading Oncology Expert As Chief Scientific Officer July 16, 2017 You'll Want to Own This Biotech Stock in the Next Market Crash April 13, 2017 Ironwood To Host Second Quarter 2017 Investor Update Call July 20, 2017
